Lataa...
Complement in Monoclonal Antibody Therapy of Cancer
Monoclonal antibodies (mAb) have been used as targeted treatments against cancer for more than a decade, with mixed results. Research is needed to understand mAb mechanisms of action with the goal of improving the efficacy of currently used mAbs, and guiding the design of novel mAbs. While some mAb-...
Tallennettuna:
| Julkaisussa: | Immunol Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381956/ https://ncbi.nlm.nih.gov/pubmed/24906530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12026-014-8542-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|